Latest Breaking News On - Mike lattanzi - Page 1 : vimarsana.com

Dr Lattanzi on Findings From the PROpel trial in mCRPC

Dr Lattanzi on Findings From the PROpel trial in mCRPC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesMike lattanziTexas oncology

Tim Jessup: Not just an engineer but a doctor - Sedona Red Rock News

Tim Jessup: Not just an engineer but a doctor - Sedona Red Rock News
redrocknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from redrocknews.com Daily Mail and Mail on Sunday newspapers.

United statesWest sedonaSan franciscoNew yorkSaratoga performing arts centerCity ofUnited kingdomRed rockLeonard bernsteinQuincy jonesNeale donald walshTim jessupJorma kaukonenEd sullivanGeorge harrisonJules verne

Dr Lattanzi on the Investigation of PARP Inhibitor Combinations in mCRPC

Dr Lattanzi on the Investigation of PARP Inhibitor Combinations in mCRPC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesMike lattanziTexas oncology

Combination Regimens Expand RCC and Prostate Cancer Treatment Armamentariums

Bupath highlights key points on the evolving standards of care in first- and second-line RCC; the role of PARP inhibitors in prostate cancer; and the potential uses for next-generation hormonal agents plus androgen deprivation therapy in frontline metastatic hormone-sensitive prostate cancer.

United statesMike lattanziUchealth tony grampsasBenjamin garmezyElizabeth kesslerManojkumar bupathiMountain cancer centers in littletonSarah cannon research institute in nashvilleInstitutional perspectivesRocky mountain cancer centersSarah cannon research instituteTony grampsas urologic cancer care clinicAnschutz medical campusTexas oncologyAustin centralRenal cell carcinoma

Dr Mike Lattanzi: Precision Oncology Options and Increasing Rates of Prostate Cancer

Mike Lattanzi, MD, genitourinary medical oncologist, Texas Oncology, discusses the importance of keeping pace with precision oncology options as rates for prostate cancer increase.

United statesMike lattanziTexas oncologyProstate cancerGenomic testingGu cancersCovid 19